72
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Integrated molecular docking, 3D QSAR and molecular dynamics simulation studies on indole derivatives for designing new Pim-1 inhibitors

, , , &
Pages 1-14 | Received 02 Dec 2019, Accepted 06 Jan 2020, Published online: 13 Jan 2020

References

  • Nawijn MC, Alendar A, Berns A. For better or for worse: the role of Pim oncogenes in tumorigenesis. Nat Rev Cancer. 2011;11(1):23–34.
  • Bachmann M, Möröy T. The serine/threonine kinase Pim-1. Int J Biochem Cell Biol. 2005;37(4):726–730.
  • Wang Z, Bhattacharya N, Weaver M, et al. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J Vet Sci. 2001;2(3):167–179.
  • Pim-1 Oncogene. 2015. http://atlasgeneticsoncology.org/Genes/GC_PIM1.html.
  • Bullock AN, Debreczeni J, Amos AL, et al. Structure and substrate specificity of the Pim-1 kinase. J Biol Chem. 2005;280(50):41675–41682.
  • Shirogane T, Fukada T, Muller JMM, et al. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity. 1999;11(6):709–719.
  • Amaravadi R, Thompson CB. The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest. 2005;115(10):2618–2624.
  • Magistroni V, Mologni L, Sanselicio S, et al. ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells. PLoS One. 2011;6(11):e28162.
  • Zhu N, Ramirez LM, Lee RL, et al. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway. J Immunol. 2002;168(2):744–754.
  • Nasser MW, Datta J, Nuovo G, et al. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem. 2008;283(48):33394–33405.
  • Eiring AM, Harb JG, Neviani P, et al. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell. 2010;140(5):652–665.
  • Thomas M, Lange-Grünweller K, Weirauch U, et al. The proto-oncogene pim-1 is a target of miR-33a. Oncogene. 2012;31(7):918–928.
  • Guo S, Mao X, Chen J, et al. Overexpression of Pim-1 in bladder cancer. J Exp Clin Cancer Res. 2010;29:161
  • Chiang WF, Yen CY, Lin CN, et al. Up-regulation of a serine/threonine kinase proto-oncogene Pim-1 in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2006;35(8):740–745.
  • Xu D, Allsop SA, Witherspoon SM, et al. The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radio resistance in human pancreatic ductal adenocarcinoma cells. Carcinogenesis. 2011;32(4):488–495.
  • Warnecke-Eberz U, Bollschweiler E, Drebber U, et al. Prognostic impact of protein overexpression of the proto-oncogene PIM-1 in gastric cancer. Anticancer Res. 2009;29(11):4451–4455.
  • Sybyl-X 2.1. St. Louis (MO): Tripos Associates; 2013.
  • Pierce AC, Jacobs M, Stuver-Moody C. Docking study yields four novel inhibitors of the protooncogene pim-1 kinase. J Med Chem. 2008;51(6):1972–1975.
  • Lee J, More KN, Yang S, et al. 3,5-Bis(aminopyrimidinyl) indole derivatives: synthesis and evaluation of pim kinase inhibitory activities. Bull Korean Chem Soc. 2014;35(7):2123–2129.
  • More KN, Jang HW, Hong VS, et al. Pim kinase inhibitory and anti proliferative activity of a novel series of meridianin C derivatives. Bioorg Med Chem Lett. 2014;24(11):2424–2428.
  • More KN, Hong VS, Lee A, et al. Discovery and evaluation of 3,5 disubstituted indole derivatives as Pim kinase inhibitors. Bioorg Med Chem Lett. 2018;28(14):2513–2517.
  • Glide, Version 5.6. New York (NY): Schrödinger LLC; 2010.
  • Friesner RA, Banks JL, Murphy RB, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47(7):1739–1749.
  • Gasteiger J, Marsili M. Iterative partial equalization of orbital electronegativity-a rapid access to atomic charges. Tetrahedron. 1980;36(22):3219–3228.
  • Desmond 3.8. New York (NY): D. E. Shaw Research; 2014.
  • Berendsen HJC, Grigera JR, Straatsma TP. The missing term in effective pair potentials. J Phys Chem. 1987;91(24):6269–6271.
  • Kaminski GA, Friesner RA, Rives JL, et al. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J Phys Chem B. 2001;105(28):6474–6487.
  • Strahan GD, Keniry MA, Shafer RH. NMR structure refinement and dynamics of the K+-[d(G3T4G3)]2 quadruplex via particle mesh Ewald molecular dynamics simulations. Biophys J. 1998;75(2):968–981.
  • Andersen HC. Rattle: a “velocity” version of the shake algorithm for molecular dynamics calculations. J Comput Phys. 1983;52(1):24–34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.